Can Probiotics Help with Constipation? Understanding Gut Motility and the Strains Behind NDS® Probiolax®
Share
Can Probiotics Help with Constipation? Understanding Gut Motility, Transit Time and the Strains Behind NDS Probiolax
Constipation and sluggish bowel transit are among the most common digestive complaints in the UK, yet they are often treated as something to simply live with. A 2024 meta-analysis confirmed that specific probiotic strains are statistically and clinically superior to placebo for constipation management. Here is what the evidence shows, which strains matter, and why the gut microbiome is central to the problem.
Constipation affects an estimated one in seven adults in the UK on a regular basis, and up to one in three older adults. It is one of the most common reasons people visit a GP for a digestive complaint, yet it is rarely approached through the lens of gut microbiome health. The research is changing that picture rapidly. The gut bacteria responsible for producing the compounds that drive bowel motility are increasingly understood to be both a primary cause of constipation and a primary target for addressing it.
What is NDS Probiolax?
NDS Probiolax is a targeted, six-strain probiotic in powder form, formulated specifically for constipation, slow bowel transit time and irregular bowel movements. It is suitable for children from one year of age, adults and the elderly, including those experiencing constipation as a side effect of demanding treatments such as chemotherapy. Each daily teaspoon delivers 15 billion CFU alongside the prebiotics FOS and inulin, which act as a food source for the bacteria and directly contribute to the short-chain fatty acid production that drives motility.
Why constipation is a gut microbiome problem
Your bowel does not move to its own schedule by chance. Gut motility, the wave-like muscular contractions that move food and waste through the intestines, is directly influenced by the bacteria living there. Beneficial microbes ferment fibre to produce short-chain fatty acids, which stimulate the contractions of the colon. They also communicate with the enteric nervous system, the vast network of nerves lining the gut sometimes called the second brain, and influence the production of serotonin, of which approximately 95% is made in the gut and which plays a direct role in triggering peristaltic movement.
When the balance of this ecosystem is disrupted, by diet, stress, illness, antibiotics or the natural changes of ageing, motility can slow and transit time lengthens. This imbalance, known as dysbiosis, with too few of the species that support movement, is a frequently overlooked contributor to chronic constipation. A longer colonic transit time is directly correlated with altered gut microbiota composition, which can be modified by introducing specific bacterial strains.
The short-chain fatty acid connection: when beneficial gut bacteria ferment prebiotic fibres like FOS and inulin, they produce butyrate, propionate and acetate. These short-chain fatty acids directly stimulate colonic smooth muscle contractions, regulate transit time and nourish the cells lining the colon wall. This is why the prebiotic component of Probiolax is as important as the bacterial strains themselves. Without the substrate, the bacteria cannot produce the compounds that drive motility.
What causes slow bowel transit and constipation?
Constipation is rarely caused by a single factor. The most common underlying contributors include:
Reduces the substrate available for beneficial bacteria to ferment, cutting short-chain fatty acid production and slowing colonic motility.
Insufficient Bifidobacterium and Lactobacillus populations reduce the bacterial drivers of bowel movement and alter the serotonin-motility signalling chain.
Disrupts the entire gut microbiome broadly, reducing beneficial bacterial populations that support transit. Post-antibiotic constipation is common and often prolonged.
Gut microbiome diversity declines with age, with Bifidobacterium populations particularly reduced in older adults. Slower transit is among the most consistent GI changes associated with ageing.
Progesterone relaxes intestinal smooth muscle and reduces peristalsis. Constipation is significantly more common in women, particularly during pregnancy, the luteal phase and perimenopause.
Chemotherapy, certain medications including opioids and iron supplements, and treatments that affect gut motility can cause or worsen constipation significantly.
What the research shows — probiotics for constipation
The evidence base for probiotics in constipation has strengthened significantly over the past two years. The question is no longer whether probiotics help with constipation but which strains, at what dose, and for how long.
A 2024 systematic review and meta-analysis confirmed that probiotics are statistically and clinically superior to placebo for constipation management across multiple outcome measures including stool frequency, stool consistency and transit time.
A broader meta-analysis from King's College London covering 30 RCTs found that 57% of probiotic users responded positively versus 44% on placebo, with Bifidobacterium lactis identified as the standout single strain for constipation specifically.
Key finding: probiotics work by gradually reshaping the gut microbial community rather than by providing immediate laxative-style relief. Most clinical trials show measurable improvements in stool frequency appearing around the end of week one to week two, with full benefits taking up to four weeks as the microbiome stabilises and gut motility patterns adjust.
Bifidobacterium lactis — the most studied strain for constipation
Bifidobacterium lactis is the single most evidence-backed probiotic strain for constipation, confirmed by the King's College London meta-analysis. Multiple clinical studies have demonstrated dose-dependent effects on whole-gut transit time, stool consistency and defecation frequency. A 2024 clinical study enrolling both healthy and constipated pregnant women found probiotic supplementation with B. lactis effectively improved Constipation Severity Scale and Bristol Stool Scale scores, increasing defecation frequency, decreasing defecation time and improving stool consistency. B. lactis is one of the six strains in NDS Probiolax.
Bifidobacterium longum — stool frequency and motility
Bifidobacterium longum is one of the dominant Bifidobacterium species in a healthy adult gut and one of the first to decline with age. A 2023 randomised double-blind placebo-controlled trial in the American Journal of Gastroenterology evaluated B. longum BB536 in 80 elderly patients with chronic constipation and found significant improvement in bowel movement frequency over the four-week intervention period. The improvement was likely mediated by metabolite production, specifically short-chain fatty acid signalling, rather than simple changes in microbiota composition. B. longum is one of the six strains in NDS Probiolax.
Lactobacillus acidophilus — motility and gut environment
Lactobacillus acidophilus is one of the most widely studied lactic acid-producing strains. By producing lactic acid, it creates the mildly acidic gut environment in which beneficial bacteria thrive and pathogenic populations are suppressed. It supports overall microbiome balance and works synergistically with Bifidobacterium strains to enhance the short-chain fatty acid production that underpins colonic motility.
Lactobacillus paracasei — microbiome resilience
L. paracasei supports microbial balance and has been studied for its role in maintaining a resilient gut microbiome under dietary and lifestyle stress, including the kind of disruption that leads to sluggish transit. It has been included in several multi-strain formulations showing clinical benefit in bowel regularity and digestive comfort.
The six strains inside NDS Probiolax
Probiolax combines six probiotic strains, each selected for its role in gut balance, with FOS and inulin, prebiotic fibres that act as food for these bacteria, helping them colonise effectively and produce the short-chain fatty acids that drive motility.
One of the first bacteria to colonise the human gut in early life, helping to maintain a healthy gut barrier and a balanced intestinal environment throughout adulthood.
The most extensively studied strain for constipation. Associated with improved transit time, increased defecation frequency and better stool consistency across multiple RCTs.
A resilient, adaptable strain that supports the gut lining, a balanced microbial community and stool frequency, particularly in elderly populations.
A classic lactic-acid-producing strain that creates the mildly acidic conditions in which beneficial bacteria thrive and motility-supporting short-chain fatty acids are produced.
Supports microbial balance and works alongside the other strains to maintain a resilient gut environment under dietary and lifestyle stress.
A naturally protective strain that produces antimicrobial compounds helping to keep the gut environment in balance and reduce pathogenic colonisation.
The formula was developed in close cooperation with the Children's Hospital of the Academic Medical Centre at the University of Amsterdam, with the strains chosen specifically for their effect on motility and their ability to support a healthy intestinal environment.
Why powder outperforms capsules for probiotics
Most probiotic capsules arrive dry in an acidic stomach environment with no time to rehydrate. A significant proportion of the bacteria do not survive the journey to the intestine where they need to work. NDS Probiolax is dissolved in lukewarm water 10 to 15 minutes before drinking, allowing the bacteria to rehydrate and reactivate before entering the body.
Manufacturer testing showed NDS powder reduced pH from 5.7 to 4.2 over five hours, confirming high bacterial activity. A competing capsule product only reduced pH from 5.7 to 5.0 over the same period. More active, viable bacteria reaching the intestine means stronger colonisation, greater short-chain fatty acid production, and more meaningful effects on bowel motility.
How to take NDS Probiolax
Who is Probiolax most suitable for?
- Adults with chronic or recurring constipation where dietary changes alone have not been sufficient
- Elderly individuals in whom Bifidobacterium populations have declined and bowel transit has slowed with age
- Children from one year of age with irregular bowel habits or constipation
- Women experiencing constipation related to hormonal changes, pregnancy or perimenopause
- Those recovering from antibiotic treatment where gut microbiome disruption has slowed transit
- Cancer patients experiencing constipation as a side effect of chemotherapy or other demanding treatments
- Those with IBS-C, the constipation-predominant subtype of irritable bowel syndrome
Honest framing on what probiotics can and cannot do for constipation
Probiotics are not stimulant laxatives. They do not produce an immediate bowel movement. They work by gradually reshaping the gut microbial community that drives motility, and this process requires consistency over two to four weeks before the full benefit is typically apparent. The 2024 meta-analysis confirms they are clinically superior to placebo, but the effect size is modest to moderate rather than dramatic. Probiolax is most valuable as part of a broader approach that includes adequate fibre intake, hydration and regular movement. If constipation is severe, persistent or accompanied by blood in the stool, unexplained weight loss or significant pain, please speak to your GP before starting any supplement.
Frequently asked questions
How long does it take for probiotics to help with constipation?
Most clinical trials show measurable improvements in stool frequency and consistency appearing around the end of week one to week two. Full benefits typically emerge over four weeks as the microbiome stabilises. For chronic constipation, consistent daily use for at least four weeks is the appropriate assessment window before concluding whether the probiotic is working.
Can I take Probiolax alongside laxatives?
Yes. Laxatives and probiotics work through entirely different mechanisms. Laxatives provide short-term symptomatic relief by stimulating the colon directly or drawing water into the bowel. Probiotics address the underlying microbiome imbalance that contributes to slow transit. They can be used alongside each other, though ideally probiotics are taken at least two hours apart from any medication to avoid interference.
Is Probiolax suitable for constipation in children?
Yes. NDS Probiolax is suitable for children from one year of age. The powder format makes dosing flexible for younger children. As with any supplement for a child, consulting a GP or paediatric practitioner before starting is advisable, particularly for children with a diagnosed condition or who are taking medication.
Can probiotics help with constipation during pregnancy?
A 2024 clinical study found probiotic supplementation with Bifidobacterium lactis effectively improved constipation outcomes in pregnant women, increasing defecation frequency and improving stool consistency. Probiolax contains B. lactis as one of its six strains. As with any supplement during pregnancy, discussing with a midwife or GP before starting is always the appropriate step.
How is Probiolax different from a regular probiotic for gut health?
The strain selection in Probiolax is specifically targeted at bowel motility and transit time rather than general gut health. The three Bifidobacterium strains, B. bifidum, B. lactis and B. longum, are the genera most consistently associated with constipation improvement in clinical research. The addition of FOS and inulin prebiotics ensures these bacteria have the substrate to produce the short-chain fatty acids that directly stimulate colonic contractions. A general probiotic is not formulated with these specific priorities.
For everyday digestive balance, look for clinically tested, practitioner-grade probiotics with strain-specific research and high bioavailability - exactly the principles behind NDS Probiolax.
NDS Probiolax contains six clinically selected strains with FOS and inulin prebiotics, formulated specifically for constipation, slow bowel transit and irregular bowel movements. Suitable for children from one year, adults and the elderly. Powder form for maximum bacterial viability. No refrigeration required.
Shop NDS Probiolax →Sources: Garzon Mora N. et al. (2024) Effectiveness of probiotics in patients with constipation: systematic review and meta-analysis; Kings College London meta-analysis, 30 RCTs, Bifidobacterium lactis constipation evidence; American Journal of Gastroenterology (2023) B. longum BB536 in elderly chronic constipation RCT; 2024 clinical study Constipation Severity Scale and Bristol Stool Scale in pregnant women; Frontiers in Pharmacology (2024) Probiotics in constipation systematic review; Biology Insights (2025) Probiotics for constipation evidence review; BioPhysics Essentials (2026) Evidence-based strains for bowel regularity.